Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) to Attend Cantech Investment Conference 2019, January 29-30 in Toronto

• Summit will highlight 100+ leading technology firms in the international cannabinoid-derived pharmaceuticals space; more than 3,500 investors are expected to attend
• LXRP is a drug delivery platform innovator with a growing IP portfolio of 10 patents granted and more than 50 patents filed globally
• LXRP out-licenses its delivery technology, such as its proprietary DehydraTECH; it holds a patent for oral delivery of all cannabinoids

Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX), a drug delivery platform innovator, will exhibit at the Cantech Investment Conference 2019, taking place on January 29-30 in Toronto, and it will participate in a specialized event where it will meet technology investors. Cantech (http://ibn.fm/KFZid) will feature an analysis of cannabis edibles, as well as a presentation on cannabis medical applications and R&D (http://ibn.fm/JKfiB).

Based in British Columbia, Canada, LXRP is a biotechnology company focused on out-licensing its disruptive delivery technology, which promotes healthier ingestion methods. LXRP holds a patent for oral delivery of all cannabinoids and has a growing IP portfolio. DehydraTECH is its absorption technology platform.

LXRP has aggressive expansion plans for 2019, having recently announced the addition of key personnel, with a special focus on its lab R&D activities (http://ibn.fm/j33eq). LXRP already has 10 patents granted in the U.S. and Australia and has filed for more than 50 patents worldwide across 10 patent families.

For more information, visit the company’s website at www.LexariaBioscience.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php